**Merger Creates Dominant HYPE Treasury: Hyperliquid Strategies Takes the Lead**
Hyperliquid Strategies has completed a landmark merger with Sonnet BioTherapeutics, now holding a massive 16.89 million HYPE tokens. This move pushes Hyperliquid Strategies’ control to over 6% of the HYPE token’s circulating supply, surpassing all competitors and solidifying its place as the leading HYPE crypto treasury. Notably, this merger also allows public investors to gain direct exposure to the Hyperliquid decentralized exchange (DEX) and blockchain via a traded vehicle.
In the wake of the announcement, HYPE’s price surged by 17%, buoyed by positive funding rates that signal bullish futures sentiment. Market watchers highlight the potential for a recovery to $40 should the token break through the $35 resistance level.
—
## What Is the Hyperliquid Strategies Merger?
The merger, first proposed in July and now finalized, establishes Hyperliquid Strategies as the dominant force in HYPE digital asset treasuries (DATs). This strategic integration allows U.S. public market investors direct participation in the Hyperliquid ecosystem, encompassing both its DEX and blockchain, through a publicly traded structure.
David Schamis, CEO of Hyperliquid Strategies, described the event as a watershed moment, saying:
> “Today marks a watershed moment: U.S. public market investors can now participate directly in the Hyperliquid ecosystem and do so through a highly liquid, publicly traded vehicle.”
With this move, Hyperliquid Strategies emerges as a key player, rivaling major treasuries in the crypto space and expanding its reach beyond legacy assets like Bitcoin and Ethereum. HYPE is now positioned alongside Binance’s BNB as one of the standout tokens outside of the BTC, ETH, and SOL trio, signaling renewed corporate interest in digital asset treasuries.
—
## How Does the HYPE Crypto Treasury Impact Market Dynamics?
Holding 16.89 million HYPE tokens (approximately $583 million at current prices), Hyperliquid Strategies now leads all HYPE digital asset treasuries. Close followers include Hyperion DeFi with 1.7 million HYPE and Lion Group Holdings, which recently added 194.7K tokens. Collectively, these treasuries now control over 6% of the circulating supply—a strong signal of institutional confidence in HYPE’s utility and future within the Hyperliquid chain.
On-chain analyst Steven has highlighted potential bids worth $265 million for more HYPE, which could further tighten circulating supply and underpin price stability. Historical data from Glassnode indicates that such concentrated treasury holdings can reduce token volatility by curbing available market float during periods of turbulence.
Industry experts agree that significant DAT accumulation fosters greater adoption over the long term. HYPE’s DEX has already seen increased volume since the merger announcement, pointing toward growing ecosystem activity and user engagement.
Merging with Sonnet BioTherapeutics not only increases operational scale but also introduces the possibility of integrating biotech-derived strategies with crypto treasury management. This hybrid approach may draw in a more diverse investor base by blending traditional finance expertise with blockchain innovation.
Data shows that tokens with large corporate treasuries—those holding over 5% supply—typically see 20-30% less volatility during market corrections. Furthermore, recent protocol upgrades on Hyperliquid have resulted in a 15% year-to-date increase in DEX volume, underscoring HYPE’s growing competitive edge in the ever-evolving DeFi landscape.
—
## Key Market Insights
– **Price Momentum:** HYPE climbed 17% post-merger news, with positive futures funding rates supporting a possible move to $40, provided Bitcoin continues its rally.
– **Supply Dynamics:** Over 6% of HYPE’s supply is now in institutional treasuries, reducing volatility and supporting the HYPE ecosystem’s sustained growth. Watch for a decisive breakout above $35.
—
## Frequently Asked Questions
**What are the key holdings in the Hyperliquid Strategies HYPE treasury?**
Post-merger, Hyperliquid Strategies holds 16.89 million HYPE tokens (valued at $583 million), followed by Hyperion DeFi (1.7 million) and Lion Group (194.7K). Collectively, these accounts hold upwards of 6% of circulating supply, highlighting HYPE’s strategic focus within its DEX and chain.
**How has the Hyperliquid merger affected HYPE’s price?**
Following the merger announcement, HYPE’s price jumped 17%, testing the $35 resistance before settling at $34.4. Bullish indicators include six days of positive funding rates and a “W” bottom pattern. There’s potential for a move to $40 if Bitcoin breaks above $96K, while downside appears capped at support between $25–$30. Market sentiment remains optimistic, with futures data showing dominant long positions. Analysts suggest a successful breach of $35 would likely spark renewed buying in line with broader crypto market trends.
—
## Conclusion
The Hyperliquid Strategies and Sonnet BioTherapeutics merger signals a turning point for crypto treasuries and public market access to digital assets. By concentrating over 6% of HYPE’s circulating supply, this move drives price momentum, reduces volatility, and strengthens the entire Hyperliquid ecosystem. Investors and market participants should keep a close watch on HYPE’s price action around the $35 resistance, as further gains could herald broader adoption and accelerated ecosystem growth.
Stay tuned for more updates and in-depth crypto market analysis.
https://bitcoinethereumnews.com/tech/hyperliquid-merger-forms-largest-hype-treasury-potentially-driving-price-recovery/
